We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.21B
AUM Growth
+$694M
Cap. Flow
+$299M
Cap. Flow %
4.15%
Top 10 Hldgs %
73.33%
Holding
137
New
11
Increased
44
Reduced
45
Closed
5

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$296M
2
PG icon
Procter & Gamble
PG
+$109M
3
HDB icon
HDFC Bank
HDB
+$15.1M
4
MRK icon
Merck
MRK
+$7.64M
5
ALKS icon
Alkermes
ALKS
+$7.35M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$77.1M
2
V icon
Visa
V
+$18.2M
3
HD icon
Home Depot
HD
+$9.27M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$9.07M
5
BIDU icon
Baidu
BIDU
+$7.1M

Sector Composition

Rank Sector Weight
1 Financials 29.05%
2 Consumer Discretionary 18.26%
3 Communication Services 15.15%
4 Healthcare 13.9%
5 Consumer Staples 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HZNP
51
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$6.88M 0.1%
415,485
+134,185
+48% +$2.05M
EXAS
52
DELISTED
Exact Sciences
EXAS
$6.74M 0.09%
112,699
+24,006
+27% +$1.29M
NVCR icon
53
NovoCure
NVCR
$1.76B
$6.67M 0.09%
213,153
+44,832
+27% +$1.25M
BMY icon
54
Bristol-Myers Squibb
BMY
$129B
$6.65M 0.09%
120,199
-63,208
-34% -$3.41M
ALKS icon
55
Alkermes
ALKS
$8.11B
$6.65M 0.09%
+161,466
New +$7.35M
AIMT
56
DELISTED
Aimmune Therapeutics
AIMT
$6.63M 0.09%
246,749
+123,466
+100% +$3.78M
XENT
57
DELISTED
Intersect ENT, Inc
XENT
$6.34M 0.09%
169,435
+58,402
+53% +$2.29M
CI icon
58
Cigna
CI
$78.4B
$6.24M 0.09%
36,723
– –
TSM icon
59
TSMC
TSM
$1.94T
$6.16M 0.09%
168,390
-1,950,333
-92% -$77.1M
PTLA
60
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$5.57M 0.08%
147,587
+54,988
+59% +$2.1M
TVRD
61
Tvardi Therapeutics
TVRD
$20.1M
$5.55M 0.08%
8,054
+1,616
+25% +$821K
PRTK
62
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5.47M 0.08%
536,128
+37,875
+8% +$429K
KTWO
63
DELISTED
K2M Group Holdings, Inc
KTWO
$5.35M 0.07%
237,603
+50,721
+27% +$1.07M
BMRN icon
64
BioMarin Pharmaceuticals
BMRN
$11.9B
$5.32M 0.07%
56,512
– –
LHCG
65
DELISTED
LHC Group LLC
LHCG
$5.02M 0.07%
+58,667
New +$4.47M
IOVA icon
66
Iovance Biotherapeutics
IOVA
$2.04B
$4.93M 0.07%
+385,446
New +$5.63M
ACRS icon
67
Aclaris Therapeutics
ACRS
$715M
$4.84M 0.07%
242,251
+166,986
+222% +$3.09M
CLVS
68
DELISTED
Clovis Oncology, Inc.
CLVS
$4.84M 0.07%
106,405
-29,943
-22% -$1.46M
ZBH icon
69
Zimmer Biomet
ZBH
$18.8B
$4.55M 0.06%
42,055
-19,373
-32% -$2.11M
GWPH
70
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.45M 0.06%
31,858
+6,148
+24% +$873K
DERM
71
DELISTED
Dermira, Inc.
DERM
$4.43M 0.06%
481,670
+360,767
+298% +$3.36M
ONCE
72
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$4.27M 0.06%
51,596
+9,822
+24% +$758K
AXDX
73
DELISTED
Accelerate Diagnostics
AXDX
$4.11M 0.06%
+18,431
New +$4.12M
RARE icon
74
Ultragenyx Pharmaceutical
RARE
$2.46B
$4.06M 0.06%
52,834
-9,143
-15% -$591K
NUVA
75
DELISTED
NuVasive, Inc.
NUVA
$3.98M 0.06%
76,399
-5,452
-7% -$286K
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2018 Portfolio in Review

As of Q2 2018, C WorldWide Group held 137 positions worth $7.21B, up 11% from $6.51B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

C WorldWide Group deployed $299M of net new capital in Q2 2018, opening 11 new positions and adding to 44 existing holdings. Its largest new stake was Procter & Gamble: 1,450,915 shares worth $113M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was TSMC, an estimated $77.1M trimmed.

  • C WorldWide Group's largest Q2 2018 buy was Procter & Gamble: 1,450,915 shares worth $113M.
  • C WorldWide Group added most to Coca-Cola in Q2 2018, an estimated $296M increase.
  • C WorldWide Group's biggest Q2 2018 reduction was TSMC, cutting an estimated $77.1M.
  • C WorldWide Group fully exited Almost Family Inc in Q2 2018, selling an estimated $1.68M.
  • C WorldWide Group's ten largest holdings make up 73% of its $7.21B portfolio in Q2 2018.
  • C WorldWide Group opened 11 new positions and closed 5 in Q2 2018.
  • C WorldWide Group's portfolio value rose 11% quarter-over-quarter to $7.21B.

Based on C WorldWide Group's 13F filing for Q2 2018, filed 3 Aug 2018.